"Baylor Scott & White Heart and Vascular Hospital is the first North Texas heart hospital solely devoted to the treatment of patients with heart conditions and cardiovascular disease. As part of Baylor Scott & White Health, Baylor Scott & White Heart and Vascular Hospital – Dallas is a nationally recognized leader in innovative, comprehensive patient care built on a tradition of excellence in collaboration with cardiologists, cardiac surgeons, and vascular surgeons on the medical staff."

During the past decade, Baylor Heart and Vascular Hospital conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 32 clinical trials were completed, i.e. on average, 82.1% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 18 clinical trials were completed. i.e. 94.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Heart and Vascular Hospital" #1 sponsor was "Boston Scientific Corporation" with 15 trials, followed by "Abbott Medical Devices" with 8 trials sponsored, "Medtronic Cardiovascular" with 6 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored and "W.L.Gore & Associates" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Heart and Vascular Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Heart and Vascular Hospital" are "Coronary Artery Disease" (16 trials), "Cardiovascular Diseases" (8 trials), "Aortic Stenosis" (4 trials), "Heart Failure" (4 trials) and "Severe Aortic Stenosis" (4 trials). Many other conditions were trialed in "Baylor Heart and Vascular Hospital" in a lesser frequency.

Most popular intervention types in "Baylor Heart and Vascular Hospital" are "Device" (50 trials), "Drug" (17 trials), "Procedure" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials), "XIENCE" (3 trials), "Empagliflozin" (2 trials) and "InnAVasc arteriovenous graft surgical implant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Heart and Vascular Hospital" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Heart and Vascular Hospital". undefined are not yet recruiting, 8 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Baylor Heart and Vascular Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Heart and Vascular Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 34 trials that are defined as “Not Applicable".